Akari Therapeutics PLC

AKTX·NASDAQ·$17.81Share Price as of 11/2·$20MMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/13/26 10-QQ1 ended 03/31/2605/19/26 10-KFY 202503/30/26 10-QQ3 ended 09/30/2511/13/25 10-QQ2 ended 06/30/2508/13/25

Disclosures

8-KCurrent report10/30/26 8-KCurrent report10/01/26 8-KCurrent report08/13/26 8-KCurrent report07/02/26 8-KCurrent report06/26/26

Prospectuses and Registrations

S-8Registration of securities for employees10/30/26 S-3/AShelf registration (amended)07/10/26 S-3/AShelf registration (amended)07/08/26 S-3Shelf registration07/02/26 S-1/ARegistration statement (amended)06/26/26

Proxies

DEF 14ADefinitive proxy10/01/26 DEF 14ADefinitive proxy06/04/26 PRE 14APreliminary proxy05/22/26 DEF 14ADefinitive proxy02/02/26 PRE 14APreliminary proxy01/22/26

Ownership

Form 4Insider transaction10/16/26 Form 4Insider transaction10/16/26 Form 4Insider transaction10/16/26 Form 4Insider transaction10/16/26 Form 4Insider transaction10/16/26

Other

EFFECTRequest for effectiveness07/13/26 EFFECTRequest for effectiveness07/07/26 DD06/03/26 RWRegistration withdrawal05/21/26 NT 10-QLate filing notification (10-Q)05/18/26